Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P28272

Entry ID Method Resolution Chain Position Source
AF-P28272-F1 Predicted AlphaFoldDB

4 variants for P28272

Variant ID(s) Position Change Description Diseaes Association Provenance
s11-25387 58 E>K strain: CLIB 95, CLIB 219, CLIB 382, CLIB 388, CLIB 413, CLIB 556, CLIB 630, K1, R12, R13, YIIc12 and YIIc17 [UniProt] No SGRP
s11-25408 65 P>S No SGRP
s11-25988 258 K>R No SGRP
s11-26137 308 R>S No SGRP

No associated diseases with P28272

3 regional properties for P28272

Type Name Position InterPro Accession
conserved_site Dihydroorotate dehydrogenase, conserved site 41 - 60 IPR001295-1
conserved_site Dihydroorotate dehydrogenase, conserved site 248 - 268 IPR001295-2
domain Dihydroorotate dehydrogenase domain 5 - 308 IPR005720

Functions

Description
EC Number 1.3.98.1 With other, known, acceptors
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
extrinsic component of membrane The component of a membrane consisting of gene products and protein complexes that are loosely bound to one of its surfaces, but not integrated into the hydrophobic region.

2 GO annotations of molecular function

Name Definition
dihydroorotate dehydrogenase (fumarate) activity Catalysis of the reaction: (S)-dihydroorotate + fumarate = orotate + succinate.
dihydroorotate dehydrogenase activity Catalysis of the reaction: (S)-dihydroorotate + A = AH(2) + orotate.

2 GO annotations of biological process

Name Definition
'de novo' pyrimidine nucleobase biosynthetic process The chemical reactions and pathways resulting in the formation of pyrimidine nucleobases, 1,3-diazine, organic nitrogenous bases, beginning with the synthesis of a pyrimidine ring from simpler precursors.
'de novo' UMP biosynthetic process The chemical reactions and pathways resulting in the formation of UMP, uridine monophosphate, starting with the synthesis of (S)-dihydroorotate from bicarbonate; UMP biosynthesis may either occur via reduction by quinone, NAD(+) or oxygen.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MTASLTTKFL NNTYENPFMN ASGVHCMTTQ ELDELANSKA GAFITKSATT LEREGNPEPR
70 80 90 100 110 120
YISVPLGSIN SMGLPNEGID YYLSYVLNRQ KNYPDAPAIF FSVAGMSIDE NLNLLRKIQD
130 140 150 160 170 180
SEFNGITELN LSCPNVPGKP QVAYDFDLTK ETLEKVFAFF KKPLGVKLPP YFDFAHFDIM
190 200 210 220 230 240
AKILNEFPLA YVNSINSIGN GLFIDVEKES VVVKPKNGFG GIGGEYVKPT ALANVRAFYT
250 260 270 280 290 300
RLRPEIKVIG TGGIKSGKDA FEHLLCGASM LQIGTELQKE GVKIFERIEK ELKDIMEAKG
310
YTSIDQFRGK LNSI